{"transactions":[{"id":4636219,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-10-06T20:35:47.000Z","date":"2026-10-02","kind":"exercise","planned":false,"acquired":false,"shares":3440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."}],"balance_after":3440,"derivative":{"underlying":"Common Stock","underlying_shares":3440},"source":{"system":"sec-edgar","filing":"0001193125-26-415649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526415649/ownership.xml","form_type":"4"}},{"id":4636218,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T20:35:47.000Z","date":"2026-10-02","kind":"exercise","planned":false,"acquired":true,"shares":3440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":141585,"source":{"system":"sec-edgar","filing":"0001193125-26-415649","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526415649/ownership.xml","form_type":"4"}},{"id":713622,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-07T20:05:02.000Z","date":"2026-07-02","kind":"exercise","planned":false,"acquired":false,"shares":3440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."}],"balance_after":6880,"derivative":{"underlying":"Common Stock","underlying_shares":3440},"source":{"system":"sec-edgar","filing":"0001193125-26-297456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526297456/ownership.xml","form_type":"4"}},{"id":713621,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T20:05:02.000Z","date":"2026-07-02","kind":"exercise","planned":false,"acquired":true,"shares":3440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":138145,"source":{"system":"sec-edgar","filing":"0001193125-26-297456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526297456/ownership.xml","form_type":"4"}},{"id":741731,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":31122,"kind":"person","name":"Nagendran Sukumar","position":1,"cik":"0001665124","reported_name":"Nagendran Sukumar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:26.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267504/ownership.xml","form_type":"4"}},{"id":741730,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:25.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267503/ownership.xml","form_type":"4"}},{"id":741737,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:23.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526267502/ownership.xml","form_type":"4"}},{"id":742049,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":19219,"kind":"person","name":"PERCEPTIVE ADVISORS LLC","position":1,"cik":"0001224962","reported_name":"PERCEPTIVE ADVISORS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":19220,"kind":"person","name":"EDELMAN JOSEPH","position":2,"cik":"0001164426","reported_name":"EDELMAN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":19221,"kind":"person","name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","position":3,"cik":"0001249675","reported_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:22.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of options to purchase shares of the Issuer's common stock awarded to Adam Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the \"Advisor\"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Joseph Edelman is the managing member of the Advisor. The Advisor serves as the investment manager to Perceptive Life Sciences Master Fund Ltd. (the \"Master Fund\"). Each of Mr. Edelman, the Advisor and the Master Fund disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman, the Advisor or the Master Fund is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267501","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1164426/000119312526267501/ownership.xml","form_type":"4"}},{"id":741729,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39286,"kind":"person","name":"Keresty Georgia","position":1,"cik":"0001773532","reported_name":"Keresty Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:20.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267500/ownership.xml","form_type":"4"}},{"id":741728,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39285,"kind":"person","name":"Freed Martin I","position":1,"cik":"0001676653","reported_name":"Freed Martin I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:19.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267499","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267499/ownership.xml","form_type":"4"}},{"id":741727,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:16.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267496","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267496/ownership.xml","form_type":"4"}},{"id":741725,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39283,"kind":"person","name":"Sullivan Lynne Marie","position":1,"cik":"0001727640","reported_name":"Sullivan Lynne Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:11.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267494/ownership.xml","form_type":"4"}},{"id":741739,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":29191,"kind":"person","name":"Stone Adam Leo","position":1,"cik":"0001727440","reported_name":"Stone Adam Leo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:04.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727440/000119312526267489/ownership.xml","form_type":"4"}},{"id":803730,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T20:05:09.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":79341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."}],"balance_after":79341,"derivative":{"underlying":"Common Stock","underlying_shares":79341},"source":{"system":"sec-edgar","filing":"0001193125-26-166736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526166736/ownership.xml","form_type":"4"}},{"id":803729,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T20:05:08.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":58847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."}],"balance_after":58847,"derivative":{"underlying":"Common Stock","underlying_shares":58847},"source":{"system":"sec-edgar","filing":"0001193125-26-166734","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526166734/ownership.xml","form_type":"4"}},{"id":803728,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T20:05:07.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":169401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."}],"balance_after":169401,"derivative":{"underlying":"Common Stock","underlying_shares":169401},"source":{"system":"sec-edgar","filing":"0001193125-26-166735","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526166735/ownership.xml","form_type":"4"}},{"id":803727,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T20:05:05.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":54925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."}],"balance_after":54925,"derivative":{"underlying":"Common Stock","underlying_shares":54925},"source":{"system":"sec-edgar","filing":"0001193125-26-166733","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526166733/ownership.xml","form_type":"4"}},{"id":803726,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T20:05:04.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":56647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."}],"balance_after":56647,"derivative":{"underlying":"Common Stock","underlying_shares":56647},"source":{"system":"sec-edgar","filing":"0001193125-26-166732","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526166732/ownership.xml","form_type":"4"}},{"id":803725,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T20:05:03.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":54925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Performance stock units (\"PSUs\") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027."}],"balance_after":54925,"derivative":{"underlying":"Common Stock","underlying_shares":54925},"source":{"system":"sec-edgar","filing":"0001193125-26-166731","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526166731/ownership.xml","form_type":"4"}},{"id":819650,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-02T20:05:06.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":false,"shares":3441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant."}],"balance_after":10320,"derivative":{"underlying":"Common Stock","underlying_shares":3441},"source":{"system":"sec-edgar","filing":"0001193125-26-140056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526140056/ownership.xml","form_type":"4"}},{"id":819649,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16070,"kind":"person","name":"SMITH IAN F","position":1,"cik":"0001197032","reported_name":"SMITH IAN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T20:05:06.000Z","date":"2026-04-02","kind":"exercise","planned":false,"acquired":true,"shares":3441,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert to common stock on a one-for-one basis."}],"balance_after":134705,"source":{"system":"sec-edgar","filing":"0001193125-26-140056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526140056/ownership.xml","form_type":"4"}},{"id":849192,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":19219,"kind":"person","name":"PERCEPTIVE ADVISORS LLC","position":1,"cik":"0001224962","reported_name":"PERCEPTIVE ADVISORS LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":19220,"kind":"person","name":"EDELMAN JOSEPH","position":2,"cik":"0001164426","reported_name":"EDELMAN JOSEPH","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":19221,"kind":"person","name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","position":3,"cik":"0001249675","reported_name":"PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (right to buy)","published_at":"2026-03-11T20:00:03.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":8912655,"price":5.609,"value":49991081.895,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The terms of the Pre-Funded Warrants provide that such warrants may not be exercised if, after such exercise, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 9.99% of the shares of Common Stock then issued and outstanding after giving effect to such exercise (the \"Beneficial Ownership Limitation\"). As of the date hereof, the Beneficial Ownership Limitation does not permit the Master Fund (as defined herein) to exercise any of its Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the \"Master Fund\"). Perceptive Advisors LLC (the \"Advisor\") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Mr. Edelman, the Advisor, and the Master Fund disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":8912655,"derivative":{"exercise_price":0.001,"exercise_date":"2026-03-09","underlying":"Common Stock","underlying_shares":8912655},"source":{"system":"sec-edgar","filing":"0001193125-26-102076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1164426/000119312526102076/ownership.xml","form_type":"4"}},{"id":896929,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:38:15.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":30031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":60063,"derivative":{"underlying":"Common Stock","underlying_shares":30301},"source":{"system":"sec-edgar","filing":"0001193125-26-057878","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057878/ownership.xml","form_type":"4"}},{"id":896928,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-19T02:38:15.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":16644,"price":5.8233,"value":96923.0052,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Cumbo on August 18, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Cumbo."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":235405,"source":{"system":"sec-edgar","filing":"0001193125-26-057878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057878/ownership.xml","form_type":"4"}},{"id":896927,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-19T02:38:15.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":30031,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":252049,"source":{"system":"sec-edgar","filing":"0001193125-26-057878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057878/ownership.xml","form_type":"4"}},{"id":896923,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:34:09.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":16250,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001193125-26-057872","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057872/ownership.xml","form_type":"4"}},{"id":896922,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:34:09.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":4134,"price":5.8233,"value":24073.5222,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Hanrahan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":74318,"source":{"system":"sec-edgar","filing":"0001193125-26-057872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057872/ownership.xml","form_type":"4"}},{"id":896921,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:34:09.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":78452,"source":{"system":"sec-edgar","filing":"0001193125-26-057872","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057872/ownership.xml","form_type":"4"}},{"id":896940,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:32:55.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":4861,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On February 13, 2024 (the \"Grant Date\") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On February 13, 2024 (the \"Grant Date\") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date."}],"balance_after":9722,"derivative":{"underlying":"Common Stock","underlying_shares":4861},"source":{"system":"sec-edgar","filing":"0001193125-26-057868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526057868/ownership.xml","form_type":"4"}},{"id":896939,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-19T02:32:55.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":2658,"price":5.8233,"value":15478.3314,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot."},{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":27474,"source":{"system":"sec-edgar","filing":"0001193125-26-057868","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526057868/ownership.xml","form_type":"4"}},{"id":896938,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-19T02:32:55.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":4861,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":30132,"source":{"system":"sec-edgar","filing":"0001193125-26-057868","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526057868/ownership.xml","form_type":"4"}},{"id":896926,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:31:37.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":7187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":14376,"derivative":{"underlying":"Common Stock","underlying_shares":7187},"source":{"system":"sec-edgar","filing":"0001193125-26-057865","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057865/ownership.xml","form_type":"4"}},{"id":896925,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:31:37.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":3616,"price":5.8233,"value":21057.0528,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":72638,"source":{"system":"sec-edgar","filing":"0001193125-26-057865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057865/ownership.xml","form_type":"4"}},{"id":896924,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:31:37.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":7187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":76254,"source":{"system":"sec-edgar","filing":"0001193125-26-057865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057865/ownership.xml","form_type":"4"}},{"id":896920,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:31:11.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":14687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":29376,"derivative":{"underlying":"Common Stock","underlying_shares":14687},"source":{"system":"sec-edgar","filing":"0001193125-26-057863","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057863/ownership.xml","form_type":"4"}},{"id":896919,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:31:11.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":7469,"price":5.8233,"value":43494.2277,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":105077,"source":{"system":"sec-edgar","filing":"0001193125-26-057863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057863/ownership.xml","form_type":"4"}},{"id":896918,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:31:11.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":14687,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":112546,"source":{"system":"sec-edgar","filing":"0001193125-26-057863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057863/ownership.xml","form_type":"4"}},{"id":896914,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:28:37.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were granted on February 13, 2024 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":21876,"derivative":{"underlying":"Common Stock","underlying_shares":10937},"source":{"system":"sec-edgar","filing":"0001193125-26-057859","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057859/ownership.xml","form_type":"4"}},{"id":896913,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:28:37.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":0,"price":5.8233,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":89466,"source":{"system":"sec-edgar","filing":"0001193125-26-057859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057859/ownership.xml","form_type":"4"}},{"id":896912,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-19T02:28:37.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":10937,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":95029,"source":{"system":"sec-edgar","filing":"0001193125-26-057859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057859/ownership.xml","form_type":"4"}},{"id":896917,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:25:06.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on February 13, 2025 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on February 13, 2025 (the \"Grant Date\") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":21250,"derivative":{"underlying":"Common Stock","underlying_shares":10625},"source":{"system":"sec-edgar","filing":"0001193125-26-057855","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057855/ownership.xml","form_type":"4"}},{"id":896916,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-19T02:25:06.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":5404,"price":5.8233,"value":31469.1132,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":99422,"source":{"system":"sec-edgar","filing":"0001193125-26-057855","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057855/ownership.xml","form_type":"4"}},{"id":896915,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-19T02:25:06.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":10625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."}],"balance_after":104826,"source":{"system":"sec-edgar","filing":"0001193125-26-057855","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526057855/ownership.xml","form_type":"4"}},{"id":916054,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-06T23:05:06.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":18894,"price":6.4419,"value":121713.2586,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":97859,"source":{"system":"sec-edgar","filing":"0001193125-26-041523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526041523/ownership.xml","form_type":"4"}},{"id":916053,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-06T23:01:54.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":48913,"price":6.4419,"value":315092.6547,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Cumbo on August 18, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Cumbo."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":222018,"source":{"system":"sec-edgar","filing":"0001193125-26-041519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526041519/ownership.xml","form_type":"4"}},{"id":916059,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T23:01:49.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":7205,"price":6.4419,"value":46413.8895,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":25271,"source":{"system":"sec-edgar","filing":"0001193125-26-041516","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526041516/ownership.xml","form_type":"4"}},{"id":916052,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-06T23:00:29.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":14783,"price":6.4419,"value":95230.6077,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":94201,"source":{"system":"sec-edgar","filing":"0001193125-26-041514","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526041514/ownership.xml","form_type":"4"}},{"id":916051,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:59:08.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":12616,"price":6.4419,"value":81271.0104,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":84092,"source":{"system":"sec-edgar","filing":"0001193125-26-041511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526041511/ownership.xml","form_type":"4"}},{"id":916050,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:57:59.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":12348,"price":6.4419,"value":79544.5812,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Hanrahan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":70327,"source":{"system":"sec-edgar","filing":"0001193125-26-041507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526041507/ownership.xml","form_type":"4"}},{"id":916049,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:56:58.000Z","date":"2026-02-04","kind":"sale","planned":true,"acquired":false,"shares":10905,"price":6.4419,"value":70248.9195,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":69067,"source":{"system":"sec-edgar","filing":"0001193125-26-041506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526041506/ownership.xml","form_type":"4"}},{"id":925159,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:18:10.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":33075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 132,300 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 132,300 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."}],"balance_after":99225,"derivative":{"underlying":"Common Stock","underlying_shares":33075},"source":{"system":"sec-edgar","filing":"0001193125-26-034089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034089/ownership.xml","form_type":"4"}},{"id":925158,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:18:10.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":93500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."}],"balance_after":93500,"derivative":{"underlying":"Common Stock","underlying_shares":93500},"source":{"system":"sec-edgar","filing":"0001193125-26-034089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034089/ownership.xml","form_type":"4"}},{"id":925157,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:18:10.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":187000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":187000,"derivative":{"exercise_price":6.6,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":187000},"source":{"system":"sec-edgar","filing":"0001193125-26-034089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034089/ownership.xml","form_type":"4"}},{"id":925156,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T01:18:10.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":56646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":56646},"source":{"system":"sec-edgar","filing":"0001193125-26-034089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034089/ownership.xml","form_type":"4"}},{"id":925155,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-03T01:18:10.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":26837,"price":6.4369,"value":172747.0853,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":108984,"source":{"system":"sec-edgar","filing":"0001193125-26-034089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034089/ownership.xml","form_type":"4"}},{"id":925154,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-03T01:18:10.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":33075,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."}],"balance_after":135821,"source":{"system":"sec-edgar","filing":"0001193125-26-034089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034089/ownership.xml","form_type":"4"}},{"id":925153,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51788,"kind":"person","name":"Tan Kevin","position":1,"cik":"0001884056","reported_name":"Tan Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-03T01:18:10.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":56646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."}],"balance_after":102746,"source":{"system":"sec-edgar","filing":"0001193125-26-034089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034089/ownership.xml","form_type":"4"}},{"id":925152,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:16:31.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":100400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 401,600 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 401,600 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."}],"balance_after":301200,"derivative":{"underlying":"Common Stock","underlying_shares":100400},"source":{"system":"sec-edgar","filing":"0001193125-26-034087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034087/ownership.xml","form_type":"4"}},{"id":925151,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:16:31.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":254900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."}],"balance_after":254900,"derivative":{"underlying":"Common Stock","underlying_shares":254900},"source":{"system":"sec-edgar","filing":"0001193125-26-034087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034087/ownership.xml","form_type":"4"}},{"id":925150,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:16:31.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":509850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":509850,"derivative":{"exercise_price":6.6,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":509850},"source":{"system":"sec-edgar","filing":"0001193125-26-034087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034087/ownership.xml","form_type":"4"}},{"id":925149,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Stock Units","published_at":"2026-02-03T01:16:31.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":169401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":169401},"source":{"system":"sec-edgar","filing":"0001193125-26-034087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034087/ownership.xml","form_type":"4"}},{"id":925148,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-03T01:16:31.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":80258,"price":6.4369,"value":516612.7202,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Cumbo on August 18, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Cumbo."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":270931,"source":{"system":"sec-edgar","filing":"0001193125-26-034087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034087/ownership.xml","form_type":"4"}},{"id":925147,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-03T01:16:31.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":100400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."}],"balance_after":351189,"source":{"system":"sec-edgar","filing":"0001193125-26-034087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034087/ownership.xml","form_type":"4"}},{"id":925146,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-03T01:16:31.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":169401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."}],"balance_after":250789,"source":{"system":"sec-edgar","filing":"0001193125-26-034087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034087/ownership.xml","form_type":"4"}},{"id":925145,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:15:55.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":27625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 110,500 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 110,500 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."}],"balance_after":82875,"derivative":{"underlying":"Common Stock","underlying_shares":27625},"source":{"system":"sec-edgar","filing":"0001193125-26-034085","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034085/ownership.xml","form_type":"4"}},{"id":925144,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:15:55.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."}],"balance_after":95000,"derivative":{"underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001193125-26-034085","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034085/ownership.xml","form_type":"4"}},{"id":925143,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:15:55.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":190000,"derivative":{"exercise_price":6.6,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001193125-26-034085","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034085/ownership.xml","form_type":"4"}},{"id":925142,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T01:15:55.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":54925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":54925},"source":{"system":"sec-edgar","filing":"0001193125-26-034085","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034085/ownership.xml","form_type":"4"}},{"id":925141,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:15:55.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":26535,"price":6.4369,"value":170803.1415,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Hanrahan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":82675,"source":{"system":"sec-edgar","filing":"0001193125-26-034085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034085/ownership.xml","form_type":"4"}},{"id":925140,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:15:55.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":27625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."}],"balance_after":109210,"source":{"system":"sec-edgar","filing":"0001193125-26-034085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034085/ownership.xml","form_type":"4"}},{"id":925139,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51787,"kind":"person","name":"Hanrahan Jessie","position":1,"cik":"0001954826","reported_name":"Hanrahan Jessie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:15:55.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":54925,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."}],"balance_after":81585,"source":{"system":"sec-edgar","filing":"0001193125-26-034085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034085/ownership.xml","form_type":"4"}},{"id":925138,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:14:47.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":28225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 112,900 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 112,900 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."}],"balance_after":84675,"derivative":{"underlying":"Common Stock","underlying_shares":28225},"source":{"system":"sec-edgar","filing":"0001193125-26-034083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034083/ownership.xml","form_type":"4"}},{"id":925137,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:14:47.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":103750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."}],"balance_after":103750,"derivative":{"underlying":"Common Stock","underlying_shares":103750},"source":{"system":"sec-edgar","filing":"0001193125-26-034083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034083/ownership.xml","form_type":"4"}},{"id":925136,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:14:47.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":207450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":207450,"derivative":{"exercise_price":6.6,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":207450},"source":{"system":"sec-edgar","filing":"0001193125-26-034083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034083/ownership.xml","form_type":"4"}},{"id":925135,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T01:14:47.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":58847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis (the \"PSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":58847},"source":{"system":"sec-edgar","filing":"0001193125-26-034083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034083/ownership.xml","form_type":"4"}},{"id":925134,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:14:47.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":28335,"price":6.4369,"value":182389.5615,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":96708,"source":{"system":"sec-edgar","filing":"0001193125-26-034083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034083/ownership.xml","form_type":"4"}},{"id":925133,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:14:47.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":28225,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."}],"balance_after":125043,"source":{"system":"sec-edgar","filing":"0001193125-26-034083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034083/ownership.xml","form_type":"4"}},{"id":925132,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51790,"kind":"person","name":"Brooks Gabriel","position":1,"cik":"0001997809","reported_name":"Brooks Gabriel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:14:47.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":58847,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis (the \"PSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 28, 2025."}],"balance_after":96818,"source":{"system":"sec-edgar","filing":"0001193125-26-034083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034083/ownership.xml","form_type":"4"}},{"id":925131,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":42275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 169,100 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 169,100 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."}],"balance_after":126825,"derivative":{"underlying":"Common Stock","underlying_shares":42275},"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925130,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":105100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."}],"balance_after":105100,"derivative":{"underlying":"Common Stock","underlying_shares":105100},"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925129,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":210200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":210200,"derivative":{"exercise_price":6.6,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":210200},"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925128,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":79341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":79341},"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925127,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:12:02.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":37771,"price":6.4369,"value":243128.1499,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":116753,"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925126,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":42275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."}],"balance_after":154254,"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925125,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":16816,"kind":"person","name":"Howton David T","position":1,"cik":"0001529297","reported_name":"Howton David T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:12:02.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":79341,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."}],"balance_after":112249,"source":{"system":"sec-edgar","filing":"0001193125-26-034080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034080/ownership.xml","form_type":"4"}},{"id":925124,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:09:48.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":24675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 98,700 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 98,700 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary."}],"balance_after":74025,"derivative":{"underlying":"Common Stock","underlying_shares":24675},"source":{"system":"sec-edgar","filing":"0001193125-26-034076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034076/ownership.xml","form_type":"4"}},{"id":925123,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:09:48.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."}],"balance_after":85000,"derivative":{"underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001193125-26-034076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034076/ownership.xml","form_type":"4"}},{"id":925122,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:09:48.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":170000,"derivative":{"exercise_price":6.6,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001193125-26-034076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034076/ownership.xml","form_type":"4"}},{"id":925121,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T01:09:48.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":false,"shares":54925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board (\"Performance Milestones\"), subject to the grantee's continued service with the Company (the \"Approval Conditions\"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the \"2026 Grant Date\") resulting in the vesting of the PSUs as to 25% of the underlying shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":54925},"source":{"system":"sec-edgar","filing":"0001193125-26-034076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034076/ownership.xml","form_type":"4"}},{"id":925120,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:09:48.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":26250,"price":6.4369,"value":168968.625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form."}],"balance_after":79972,"source":{"system":"sec-edgar","filing":"0001193125-26-034076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034076/ownership.xml","form_type":"4"}},{"id":925119,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:09:48.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":24675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSUs\") converts to common stock on a one-for-one basis."}],"balance_after":106222,"source":{"system":"sec-edgar","filing":"0001193125-26-034076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034076/ownership.xml","form_type":"4"}},{"id":925118,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":51789,"kind":"person","name":"Herzich Paul","position":1,"cik":"0001954991","reported_name":"Herzich Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-03T01:09:48.000Z","date":"2026-01-29","kind":"exercise","planned":true,"acquired":true,"shares":54925,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance stock unit (\"PSUs\") converts to common stock on a one-for-one basis."}],"balance_after":81547,"source":{"system":"sec-edgar","filing":"0001193125-26-034076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526034076/ownership.xml","form_type":"4"}},{"id":925228,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:07:46.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On January 31, 2025 (the \"2025 Grant Date\"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary"}],"balance_after":45000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-034072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526034072/ownership.xml","form_type":"4"}},{"id":925227,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-03T01:07:46.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":35450,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary."}],"balance_after":35450,"derivative":{"underlying":"Common Stock","underlying_shares":35450},"source":{"system":"sec-edgar","filing":"0001193125-26-034072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526034072/ownership.xml","form_type":"4"}},{"id":925226,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:07:46.000Z","date":"2026-01-29","kind":"grant","planned":true,"acquired":true,"shares":70900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 29, 2026 (the \"2026 Grant Date\") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary."}],"balance_after":70900,"derivative":{"exercise_price":6.6,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":70900},"source":{"system":"sec-edgar","filing":"0001193125-26-034072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526034072/ownership.xml","form_type":"4"}},{"id":925225,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-03T01:07:46.000Z","date":"2026-01-31","kind":"exercise","planned":true,"acquired":true,"shares":15000,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":32476,"source":{"system":"sec-edgar","filing":"0001193125-26-034072","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526034072/ownership.xml","form_type":"4"}},{"id":927014,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-30T21:05:07.000Z","date":"2026-01-27","kind":"exercise","planned":true,"acquired":false,"shares":3884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3884},"source":{"system":"sec-edgar","filing":"0001193125-26-031765","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526031765/ownership.xml","form_type":"4"}},{"id":927013,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-30T21:05:07.000Z","date":"2026-01-27","kind":"exercise","planned":true,"acquired":false,"shares":389,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On January 27, 2022 (the \"Grant Date\") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On January 27, 2022 (the \"Grant Date\") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":389},"source":{"system":"sec-edgar","filing":"0001193125-26-031765","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526031765/ownership.xml","form_type":"4"}},{"id":927012,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T21:05:07.000Z","date":"2026-01-27","kind":"exercise","planned":true,"acquired":true,"shares":3884,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship."}],"balance_after":99297,"source":{"system":"sec-edgar","filing":"0001193125-26-031765","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526031765/ownership.xml","form_type":"4"}},{"id":927011,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39287,"kind":"person","name":"Ganot Ilan","position":1,"cik":"0001727460","reported_name":"Ganot Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-30T21:05:07.000Z","date":"2026-01-28","kind":"sale","planned":true,"acquired":false,"shares":191,"price":6.59,"value":1258.69,"ownership":{"direct":false,"nature":"Wife"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot."},{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot."}],"balance_after":17476,"source":{"system":"sec-edgar","filing":"0001193125-26-031765","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727460/000119312526031765/ownership.xml","form_type":"4"}}],"next_cursor":"2026-01-30T21:05:07.000000Z,927011"}